News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Mergers and Acquisitions
T-Bird Pharma Inc. Announces Closing Of Transaction With Medna Biosciences 4/24/2015
Zogenix (ZGNX) Closes Sale Of Zohydro ER Business To Pernix (PTX) 4/24/2015
Could Google (GOOG) Be a Buyer for Former Merck & Co. (MRK) HQ? 4/23/2015
Small Biotech Clovis Oncology (CLVS)'s Breakthrough Drugs May Catch the Eye of Pfizer (PFE), Roche (RHHBY) 4/23/2015
How Abbott (ABT) is Reaping Rewards From Teva (TEVA)'s Bid for Mylan (MYL) 4/23/2015
Novartis AG (NVS) Hunts for Bolt-On Acquisitions Worth $2 Billion to $5 Billion 4/23/2015
Rumors Swirl Pfizer (PFE) Will Bid for AstraZeneca PLC (AZN) Again 4/23/2015
Why Ariad (ARIA) Could Be Worth $3 Billion to a Big Drugmaker 4/23/2015
Teva (TEVA) Files For Hart-Scott-Rodino Notification Regarding Proposed Acquisition Of Mylan (MYL) 4/22/2015
Roche (RHHBY) CEO Not Interested in Megamergers, Only New Products and Technologies 4/22/2015
DuPont (DD) Acquires Taxon Biosciences, Inc. 4/22/2015
BREAKING: Perrigo (PRGO) Rejects $30B Mylan (MYL) Bid, Says Deal "Substantially Undervalues" Irish Firm 4/21/2015
Teva (TEVA) Finally Makes Mylan (MYL) Bid Official, With $40 Billion Offer For Biggest Takeover in 2015 4/21/2015
Actelion Ltd. (ALIOF.PK) CFO Actively Hunting for M&A Opportunities 4/21/2015
Concordia Healthcare (CXR.TO) Announces Completion Of Acquisition Of Covis Pharma Commercial Assets For U.S. $1.2 Billion 4/21/2015
Tartan Holdings, LLC Acquires Real Estate And Assets From Moog Inc.; Launches iuvo BioScience 4/21/2015
Omnicell Closes Acquisition Of Germany-Based MACH4 Pharma Systems 4/21/2015
Daiichi Sankyo Dumps $3.6 Billion Sun Pharma (SUNPHARMA.NS) Stake 4/20/2015
Teva (TEVA) Will Bid For Mylan (MYL), Say Sources, As Tug-of-War Continues 4/20/2015
AbbVie (ABBV) Extends Exchange Offer To Acquire Pharmacyclics (PCYC) 4/20/2015
Intrexon Corporation Completes Acquisition Of Okanagan Specialty Fruits 4/20/2015
Agilent Technologies Inc. (A) Recommends Stockholders Reject TRC Capital’s “Mini-Tender” Offer 4/20/2015
Mallinckrodt (MNK) Completes Acquisition Of Ikaria 4/17/2015
Sartorius Stedim Biotech Acquires UK-based CRO, BioOutsource 4/17/2015
As Proxy Fight Continues, Five Companies That May be Eyeing Ariad (ARIA) 4/16/2015
Three Biotechs Well-Positioned for M&A: Gilead (GILD), Celgene (CELG), and Biogen (BIIB) 4/16/2015
LGC Acquires Biosearch Technologies And Extends Its Expertise In The qRCR Market 4/15/2015
Is Johnson & Johnson (JNJ) Eyeing Large M&As? 4/15/2015
Talent Exodus From Banks Continues as Healthcare M&A Thrives 4/14/2015
Roche (RHHBY) Grabs CAPP Medical, a "Liquid Biopsy" Startup Targeting Cancer 4/14/2015
ProtoKinetix Inc. (PKTX.OB) Announces Acquisition Of Patents 4/14/2015
Merck & Co. (MRK) Still Trying to Squeeze Out Worth From $50 Billion Schering-Plough (SGP) Buyout 4/13/2015
Cipher Pharma (DND.TO) Nabs INNOCTIS and Experienced U.S. Sales Force for $45 Million Cash 4/13/2015
Mylan (MYL) Notifies Perrigo Company (PRGO) Of HSR Filing Regarding Proposed Acquisition 4/13/2015
Recro Pharma (REPH) Completes Acquisition Of IV/IM Meloxicam And CGMP Manufacturing Facility And Business Unit From Alkermes (ALKS) 4/13/2015
Accovion Signs Agreement To Be Acquired By Clinipace Worldwide 4/13/2015
Hi-Tech Pharmaceuticals To Acquire Advanced Pharmaceuticals and Nutritionals ("APN") Creating A Top Tiered Global OTC Pharmaceutical and Nutraceutical Company 4/13/2015
The Inside Story Behind Cellular Dynamics’ $307 Million Sale To FUJIFILM 4/10/2015
Karo Bio AB Acquires Product For Treatment Of Common Cold 4/10/2015
Mylan (MYL) Proposes To Acquire Perrigo (PRGO) For $205 Per Share 4/9/2015
Bristol-Myers Squibb (BMY) Completes Previously Announced Acquisition Of Flexus Biosciences 4/8/2015
Agenus (AGEN) Acquires Celexion Assets And Expands Its Antibody Discovery Platform 4/8/2015
Panther Biotechnology Announces Agreement To Acquire Technology Assets Of Faulk Pharmaceuticals 4/7/2015
SoCal's Receptos (RCPT) Seeks Partnerships But Gains Takeover Interest Instead 4/3/2015
Janssen Pharmaceutical Completes Divestiture Of U.S. License Rights To NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) Extended-Release Tablets And NUCYNTA (tapentadol) Oral Solution To Depomed, Inc. (DEPO) 4/3/2015
Depomed, Inc. (DEPO) Announces Closing Of Acquisition Of U.S. Rights To NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) Extended Release Tablets And NUCYNTA (tapentadol) Oral Solution From Janssen Pharmaceutical For $1.05 Billion 4/3/2015
EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN) "Seems Obvious," Source Close to the Deal Tells BioSpace (DHX) 4/2/2015
With A Few Short Words, Salix (SLXP) As A Company Disappears 4/2/2015
Former Allergan (AGN) CEO Pyott Sees $534M Cash Payday After Stock Sale 4/2/2015
Daiichi Sankyo Cuts-and-Pastes for 5-Year Plan: Sister Companies Daiichi Sankyo, Inc. (DSNKY) and Asubio Pharma Co., Ltd. Merge 4/1/2015
Infinity Pharmaceuticals Inc. (INFI) Shells Out $52.5M to Purchase Cancer Drug Royalties From Takeda (TKPYY) 4/1/2015
Valeant (VRX) Completes Acquisition Of Salix (SLXP) 4/1/2015
Dr. Reddy's Laboratories Ltd. (RDY) To Acquire Select Portfolio Of The Established Products Business Of UCB In India 4/1/2015
Teva (TEVA) Shells Out $3.2B to Buy Auspex Pharmaceuticals (ASPX) and Boost CNS Business; All Cash, No Debt 3/31/2015
RedHill Biopharma Ltd. (RDHL) Will Snag Small Molecule Rights from Apogee for $5.5M 3/31/2015
Japan's FUJIFILM to Acquire U.S. Cellular Dynamics for $307M 3/31/2015
Horizon Pharma (HZNP) Acquires Hyperion Therapeutics (HPTX) and Its Revenue-Boosting Pipeline for $1.1B 3/31/2015
Ferring Pharmaceuticals Receives FDA Approval For Growth Hormone Name Change, Acquires ZOMACTON [Somatropin (rDNA Origin)] For Injection And Needle-Free Device In The U.S. 3/31/2015
Amneal Signs Deal To Acquire The Generic Business Of Actavis (ACT) Australia 3/31/2015
FUJIFILM To Acquire Cellular Dynamics 3/30/2015
BIOSAFE Goes Direct in Brazil, Acquiring Its Local Distributor 3/30/2015
Columbia Laboratories, Inc. (CBRX) Acquires Exclusive Worldwide License To A Novel Segmented Intra-Vaginal Ring Delivery Technology 3/30/2015
Perrigo Company (PRGO) Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3/30/2015
Solasia Acquires Exclusive License And Distribution Rights From Camurus For Episil Oral Liquid In Japan And China 3/30/2015
Synergy Pharmaceuticals May Be for Sale 3/27/2015
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/27/2015
Karolinska Development AB Sells Its Stake In Axelar To Östersjöstiftelsen 3/27/2015
PAREXEL International (PRXL) Announces Execution Of Definitive Agreement To Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3/26/2015
FSC Laboratories To Market Cefaclor For Oral Suspension In The U.S. 3/26/2015
Salix (SLXP) Had a $13 Billion Offer on the Table From Allergan (AGN) Before Accounting Problems Smashed Share Price 3/25/2015
Sun Pharma (SUNPHARMA.NS) Announces Closure Of Merger Deal With Ranbaxy 3/25/2015
Life Post-Ranbaxy Laboratories (RANBAXY.BO)? Sun Pharma (SUNPHARMA.NS) Holds On to $300 Million and Hunts for More M&As 3/25/2015
APR Applied Pharma Research S.A. Today Announced That HBM Partners AG (“HBM”) Has Acquired A Minority Stake In APR 3/25/2015
Buy This Stock to Bet on Biogen (BIIB) Drug, Says Raymond James & Associates 3/24/2015
Accellta Grants Exclusive Rights for Micro-Carrier Free Stem Cells Suspension Culture To StemCell Technologies Inc. 3/24/2015
Bristol-Myers Squibb (BMY) Acquires Exclusive License From Novo Nordisk A/S (NVO) For A Discovery Research Program Focused On Autoimmune Diseases 3/24/2015
Recent Signs Mylan (MYL) May be Gobbled Up by Teva (TEVA) 3/23/2015
Cipher Pharmaceuticals (DND.TO) Acquires Canadian Rights To Novel Treatment For Psoriasis And Rheumatoid Arthritis 3/23/2015
Biophage Pharma Inc. Announces The Conclusion Of A Conditional Asset Purchase Agreement 3/23/2015
AstraZeneca PLC (AZN) Trudges Behind in Cancer Race Where Losing May Force a Buyout 3/20/2015
Johnson & Johnson (JNJ)'s Janssen Pharmaceutical Snaps Up Virtual Biopharma XO1 Limited for Hush Hush Price 3/19/2015
Tyme Technologies Completes Reverse Merger 3/19/2015
Heraeus Medical Components Enters Agreement To Acquire NeoMetrics 3/19/2015
Prestium Pharma, Inc. Acquires ZONALON (Doxepin Hydrochloride), 5% Cream; Continues To Expand Its Product Portfolio 3/19/2015
Ignyta (RXDX) Shells Out $41.6 Million for Teva (TEVA)'s Oncology Assets 3/18/2015
Genmab A/S (GEN.CO) Acquires Antibody Assets From iDD Biotech 3/18/2015
Pharmalink AB Acquires Novel Therapeutic Product Candidate For Treating Inflammation Associated With Osteoarthritis 3/18/2015
Depomed, Inc. (DEPO) Announces Termination Of Hart-Scott-Rodino Waiting Period For Pending Acquisition Of NUCYNTA Franchise From Janssen Pharmaceutical Inc. 3/17/2015
Actavis (ACT) Completes Allergan (AGN) Acquisition 3/17/2015
Kite Pharma (KITE) Strengthens Its T Cell Receptor (TCR) Cancer Gene Therapy Platform Through Acquisition Of T-Cell Factory B.V. (TCF) 3/17/2015
Valeant (VRX) Sweetens Salix (SLXP) Deal to $173 Per Share After Teaming Up With Ackman and Endo International (ENDP) Withdraws 3/16/2015
Valeant (VRX) Announces HSR Clearance For Salix (SLXP) Acquisition 3/16/2015
European Commission (EC) Clears Actavis (ACT)' Pending Acquisition Of Allergan (AGN) 3/16/2015
Ruthigen And Pulmatrix Enter Into Merger Agreement 3/16/2015
Salix (SLXP) Sale Could Mean 220 Job Losses, But There is a Silver Lining 3/13/2015
GlaxoSmithKline (GSK) Pockets $853 Million by Halving Stake in Aspen Pharmacare 3/13/2015
Employees at Three Major Biopharmas Remain Uncertain, As Salix (SLXP) Confirms Bid From Endo International (ENDP) 3/13/2015
Epizyme (EPZM) Reacquires Rights to Cancer Drug From Eisai Company (ESALY.PK) in Deal Worth $110 Million 3/12/2015
Mounting Hospira Recalls and Plant Woes Will Soon be Pfizer (PFE)'s Problem 3/12/2015
Porton Fine Chemicals Pays $41.5 Million To Acquire Dongbang Pharma 3/12/2015
LMC Diabetes & Endocrinology And Manna Research Merge Research Programs 3/12/2015
Salix (SLXP) Confirms Receipt Of An Unsolicited Proposal From Endo International (ENDP) 3/12/2015
Ember Therapeutics And Mariel Therapeutics Enter Definitive Merger Agreement Creating A Strong Diversified Company 3/12/2015
Acadia (ACAD) Stock Hits All-Time High as Canceled Meetings Spur M&A Rumors 3/11/2015
San Diego's Zogenix (ZGNX) Dumps Painkiller Biz to Pernix (PTX) in Deal Worth $383.5 Million 3/11/2015
AbbVie (ABBV), Johnson & Johnson (JNJ) Tempted to Take Over $650 Million Galapagos (GLPG.BR) 3/11/2015
Valeant (VRX) Squirms as Endo International (ENDP) Makes Competing Offer for Salix (SLXP) 3/11/2015
Actavis (ACT) And Allergan (AGN) Shareholders Approve Proposals Related To Actavis' Planned Acquisition Of Allergan 3/11/2015
Ackman Gobbles Up Almost Five Percent Stake in Valeant (VRX) 3/10/2015
IMPAX Labs (IPXL) Completes Acquisition Of Tower Holdings, Inc. And Lineage Therapeutics Inc. 3/10/2015
Transcat, Inc. (TRNS) Expands Midwest Presence With Acquisition Of Apex Metrology Solutions 3/10/2015
Regen BioPharma Acquires Issued Patent And Preclinical Data Package For Targeting Cancer Stem Cell 3/10/2015
Concordia Healthcare (CXR.TO) Snags Some Assets of Covis Pharma for $1.2 Billion 3/9/2015
Bay Area's Catalyst Biosciences to Merge With Unlucky Targacept (TRGT) 3/9/2015
Orgenesis Acquires Cell Therapy Manufacturer MaSTherCell 3/9/2015
Alkermes (ALKS) Dumps Georgia Facility, Pain Drug Rights to Recro Pharma (REPH) in $170 Million+ Deal 3/9/2015
Radius (RDUS) Announced Today That It Has Acquired The License To Develop And Market RAD1901 In Japan, And Has Hired Dinesh Purandare, Former Sanofi (SAN.PA) Oncology Executive To The Position Of Senior Vice President (SVP) And Head Of Global Oncology At Radius 3/9/2015
AbbVie (ABBV) Outbids Johnson & Johnson (JNJ) and Lands Pharmacyclics (PCYC) for $21 Billion 3/6/2015
Novartis AG (NVS) Unloads RNAi Portfolio to Arrowhead Research Corporation (ARWR) for $35 Million 3/6/2015
Mallinckrodt (MNK) Forks Out $2.3 Billion for Respiratory Drug and Device Maker Ikaria 3/6/2015
Tekmira (TKMR) Announces Completion Of The Merger With Oncore Creating A Leading Hepatitis B Solutions Company 3/5/2015
ANI Pharmaceuticals, Inc. Acquires Generic Drug Product From Teva (TEVA) 3/5/2015
Novartis AG (NVS) Will Move Past Scandal While Hunting for More M&A in the $2-5 Billion Range, Says CEO 3/5/2015
Baxter International (BAX) Snaps Up German Biopharma for $225 Million 3/5/2015
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged 3/4/2015
Boston Scientific (BSX) Snags Endo International (ENDP)'s Urology Portfolio in Deal Worth $1.65 Billion 3/4/2015
99.5% Of Tekmira (TKMR) Shareholders Vote In Favor Of Merger 3/4/2015
Allenex AB Acquires All Remaining Minority Interests In The Group 3/4/2015
Veeva Systems, Inc. Announces Intent To Acquire Key Opinion Leader (KOL) Solutions Business 3/4/2015
Sun Pharma (SUNPHARMA.NS) Snaps Up GlaxoSmithKline (GSK)'s Opiates Business 3/3/2015
Cardinal Health (CAH) Ponies Up $1.944 Billion Cash for Johnson & Johnson (JNJ)'s Cordis (JNJ) 3/3/2015
Intrexon Corporation To Acquire Okanagan Specialty Fruits 3/2/2015
Mesa Labs (MLAB) Acquires Its UK And Germany Distribution Of Biological Indicators 3/2/2015
ICON Completes Acquisition Of MediMedia Pharma Solutions 3/2/2015
Genstar Capital L.P. Backed eResearch Technology Inc. (ERT) (ERES) To Acquire PHT Corporation 3/2/2015
Bay Area's Pharmacyclics (PCYC) Mulls Possible $18 Billion Sale; Johnson & Johnson (JNJ),Novartis AG (NVS) Interested 3/2/2015
ERT To Acquire PHT Corporation 2/27/2015
Omnicell Signs Agreement To Acquire Germany-Based Pharmacy Automation Provider, MACH4 Pharma Systems 2/27/2015
Mylan Inc. (MYL) Completes Acquisition Of Abbott (ABT)'s Non-U.S. Developed Markets Specialty And Branded Generics Business 2/27/2015
Allergan (AGN) CEO May Pocket $100 Million If Terminated After Buyout 2/26/2015
Biota Pharmaceuticals, Inc. (BOTA) Grabs Anaconda Pharma in $38 Million Deal 2/26/2015
Cipher Pharmaceuticals (DND.TO) Acquires Three Products From Astion Pharma 2/26/2015
Tekmira (TKMR) Announces Update To Its Proxy Circular On The Proposed Business Combination With Oncore 2/26/2015
JSR Corporation And KBI BioPharma Agree To Acquisition; INCJ And CMIC Of Japan Also Participate 2/26/2015
Shares Rise as Suitors Like Shire (SHPGY) and BioMarin (BMRN) Circle Around PTC Therapeutics (PTCT) 2/25/2015
Phosphagenics Limited (POH.AX) Decides To Sell BioElixia Cosmetics Brand 2/25/2015
Bristol-Myers Squibb (BMY) Snaps Up Private Cancer Drugmaker in $1.25 Billion Buyout 2/24/2015
Shire (SHPGY) Beefs Up Late-Stage Pipeline With $70 Million+ Meritage Pharma Buy 2/24/2015
BioNJ Announces Purchasing Consortium, Designed With Member Savings In Mind 2/24/2015
Eli Lilly (LLY) Steers Clear of Deals as It Eyes Moon Shot Drugs 2/24/2015
Ipsen (IPN.PA) Enters Into Option Agreement To Acquire Canbex Therapeutics 2/24/2015
Bayer AG (BAYZF) May Have a Buyer for Diabetes Biz 2/23/2015
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc. 2/23/2015
EXCLUSIVE: Evercore ISI Breaks Down Valeant (VRX) / Salix (SLXP) Deal By the Numbers 2/23/2015
Shire (SHPGY) Completes Acquisition Of NPS Pharmaceuticals, Inc. (NPSP) 2/23/2015
Sosei Snags UK Biotech Firm Heptares for $400 Million 2/23/2015
Marathon Pharmaceuticals, LLC Prepares For Launch Of New Rare Disease Treatments By Selling Non-Strategic Products To Valeant (VRX) Including Isuprel And Nitropress 2/23/2015
Management Buy Out Of Synexus Backed By LDC; The Deal Will Enable It To Further Expand Its Global Network 2/23/2015
Spending Spree Continues as Valeant (VRX) Officially Snags Salix (SLXP) for $14.5 Billion 2/23/2015
Actavis (ACT) to Officially Adopt Allergan (AGN) Name 2/20/2015
Ferring Pharmaceuticals Acquires Two Phase III Ready Orthobiologic Product Candidates From BioSET 2/19/2015
Actavis (ACT) Not Done, Still Eyes "Couple Billion Dollar" Deals to Fill Pipeline 2/19/2015
Endo Pharmaceuticals (ENDP) Rumored to be Battling Shire (SHPGY), Valeant (VRX) for Salix (SLXP)'s Affections 2/18/2015
Manhattan Scientifics, Inc. To Immediately Receive $8 Million As It Reacquires Its Nano-Structured Metals Technology And Related Intellectual Property And Equipment 2/18/2015
Crown Bioscience, Inc. Buys PDX Unit From Molecular Response (MRL) 2/18/2015
Amneal, Pfizer (PFE), Novartis AG (NVS) Eye Takeover of CLARIS Lifesciences's Injectables Biz 2/17/2015
Charles River Laboratories Hunts for M&As; Close to Sealing Deal With Unnamed Drug Discovery Startup 2/17/2015
Vaxin, Inc. Enters Definitive Agreement To Acquire Immune Targeting Systems (ITS) Ltd.; Secures $16M In New Financing 2/17/2015
Novartis AG (NVS) Eyes Israeli Companies 2/16/2015
Allergan (AGN) CEO's Take on How to Survive an Activist Attack 2/16/2015
Look Out Valeant (VRX), Shire (SHPGY) Wants to Continue Spending Spree With Salix (SLXP) Bid 2/16/2015
Week in Review: Cellular Biomedicine Group (CBMG) In-Licenses Cancer Immunotherapy From China 2/16/2015
Valeant (VRX) Secures Financing to Make Rumored $9.6 Billion Bid for Salix (SLXP) 2/13/2015
Gilead (GILD) Hungry For Oncology M&A, Bullish On Hep C Cash Flow: Citi 2/13/2015
Intrexon Corporation Snaps Up Belgium Startup ActoGeniX for $60 Million 2/13/2015
Actavis (ACT) To Divest Pharmatech, Inc. To TPG 2/13/2015
It's Official: Valeant (VRX) to Buy Bankrupt Vaccine Maker for $400 Million Cash 2/12/2015
KYTHERA Biopharmaceuticals, Inc. (KYTH) Acquires Worldwide Rights To Clinical Compound And Key Intellectual Property For Potential Novel Treatment Of Hair Loss 2/11/2015
Zoetis (ZTS) Completes Purchase Of Animal Health Assets Of Abbott Laboratories (ABT) 2/11/2015
AmerisourceBergen Corporation (ABC) Announces Expiration Of The Hart-Scott-Rodino Waiting Period For Amerisourcebergen’s Proposed Acquisition Of MWI Veterinary Supply 2/11/2015
GlaxoSmithKline (GSK) Takes Full Control of GlycoVaxyn AG for $190 Million 2/11/2015
Actavis (ACT) Unloads Another Product Line for $50 Million 2/10/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
Pfizer (PFE) Not Done With Deals, May Still Break Up After $17 Billion Buy 2/9/2015
Cellular Biomedicine Group (CBMG) Acquires CAR-T Technology From China Hospital 2/9/2015
Cellular Biomedicine Group (CBMG) Acquiring Chinese PLA General Hospital's CAR-T (CD19/CD20/CD30/EGFR) Immuno-Oncology Technology And Clinical Data 2/9/2015
Valeant (VRX) Ups Bid for Dendreon (DNDN) Assets to $400 Million After Competing Offers Come In 2/6/2015
AstraZeneca PLC (AZN) Who? Pfizer (PFE) Snatches Up Hospira for $17 Billion Cash 2/6/2015
AstraZeneca PLC (AZN) Slams Down $600 Million for Actavis (ACT) Lung Unit 2/5/2015
Roper Industries Announces Two Medical Software Acquisitions 2/5/2015
Oncore And Tekmira (TKMR) Files For Merger – Releases Further Details About License Agreement With NeuroVive Pharmaceutical AB 2/5/2015
Dendreon Corporation (DNDN) Enters Into Amended Agreement With Valeant (VRX) In Connection With Court-Supervised Sales Process 2/5/2015
Deal-Hungry Valeant (VRX) Eyes Salix Pharmaceuticals, Ltd. (SLXP) as Its Latest Takeover Target 2/5/2015
Harbin Gloria Pharmaceuticals (002437.SZ) Acquires Shanxi Powerdone For $380 Million 2/4/2015
The Medicines Company (MDCO) Acquires Annovation Biopharma, Inc. 2/4/2015
Hainan Shuangcheng Buys Hangzhou Ausia Biotech Stake For $154 Million 2/4/2015
Mylan Inc. (MYL) to Become a Women's Healthcare Powerhouse With $800 Million Buy 2/3/2015
VWR Acquires National Biochemicals 2/3/2015
Sanofi (SAN.PA)'s Increased Stake in Alnylam Pharmaceuticals (ALNY) Points Toward a Possible Acquisition 2/2/2015
Dendreon Corporation (DNDN) Gets $296 Million Cash Bid From Deal-Hungry Valeant (VRX) for Provenge Assets as Bankruptcy Auction Looms 2/2/2015